Cart
sales@molnova.com
STS-E412
CAS No. 1609980-39-3
STS-E412( —— )
Catalog No. M34036 CAS No. 1609980-39-3
STS-E412 is a tissue-protective and selective EPOR/CD131 receptor activator for the study of neurological disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 88 | Get Quote |
|
| 5MG | 132 | Get Quote |
|
| 10MG | 211 | Get Quote |
|
| 25MG | 364 | Get Quote |
|
| 50MG | 601 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSTS-E412
-
NoteResearch use only, not for human use.
-
Brief DescriptionSTS-E412 is a tissue-protective and selective EPOR/CD131 receptor activator for the study of neurological disorders.
-
DescriptionSTS-E412 is a selective activator of tissue-protective EPO receptor (including EPOR and CD131). STS-E412 can be used for research of neurodegenerative diseases and organ protection.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1609980-39-3
-
Formula Weight318.76
-
Molecular FormulaC15H15ClN4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (156.86 mM; Ultrasonic )
-
SMILESCc1cc(C)n2nc(OCCOc3ccc(Cl)cc3)nc2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Miller JL, et al. Discovery and Characterization of Nonpeptidyl Agonists of the Tissue-Protective Erythropoietin Receptor. Mol Pharmacol. 2015 Aug;88(2):357-67.?
molnova catalog
related products
-
Mitiperstat
Mitiperstat is a potent myeloperoxidase (MPO) inhibitor that is effective in preventing cardiovascular diseases such as heart failure and coronary artery disease.
-
3-Morpholino-1-(4-(2...
3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one shows antitumor activity in a human colon cancer cell line and may be used to combat thrombosis.
-
Disitamab
Disitamab Vedotin (RC48-0) is a humanized monoclonal antibody that targets HER2 and can be utilized in creating antibody-drug conjugates (ADCs), specifically referred to as Disitamab Vedotin .
